3B BlackBio Dx Limited conducted a one-to-one meeting with Fortuna Asset Managers LLP, Delhi on Saturday, 21st November 2026. The meeting commenced at 12:00 hrs India Time and concluded at 13:00 hrs India Time, lasting exactly one hour.
The interaction was conducted in compliance with Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015. This meeting serves as a continuation of the company's earlier communication referenced under Ref. No.P-66/2026-27/55 dated 16th November 2026.
During the meeting, the company specifically discussed information that is already available in the public domain. The company reiterated the information previously shared through its Q2-FY27 Investor Presentation, which was originally intimated to the Stock Exchanges under Ref. No.P66/2026-27/53 dated 13th November 2026.
The company explicitly confirmed that no unpublished price sensitive information pertaining to the company was shared with the investor during this meeting.
A web link to the investor presentation was provided: https://www.kilpest.com/upload/Investor%20Presentation%20November%202026.pdf. This presentation covers the financial results for the quarter and half year ended 30-09-2026.
The disclosure was signed by Nikhil Kuber Dubey, Whole Time Director (DIN: 00538049), on November 21, 2026 at 13:43:28 +05'30'.